Raynham, Mass.-based DePuy Synthes; Dublin, Ireland-based Medtronic; San Diego-based NuVasive; Kalamazoo, Mich.-based Stryker; and Warsaw, Ind.-based Zimmer Biomet dominate the MIS market.
A growing number of spinal disorder cases will spur market growth, as well as the increasing adoption of the MI sacroiliac joint fusion technique. A dearth of skilled surgeons in MIS techniques will pose as an obstacle to market growth, however.
More articles on MIS:
Minimally invasive vs. open spine surgery for spondylolisthesis: 5 things to know
MIS surgeon Dr. Douglas Slaughter joins ranks of NJ Spine & Orthopedic — 5 notes
4 key notes on defensive medicine for spine-focused neurosurgeons — premiums reach $104k
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
